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There is now substantial evidence that compounds released during host stress directly activate the virulence of certain
opportunistic pathogens. Here, we considered that endogenous opioids might function as such compounds, given that
they are among the first signals to be released at multiple tissue sites during host stress. We tested the ability of
various opioid compounds to enhance the virulence of Pseudomonas aeruginosa using pyocyanin production as a
biological readout, and demonstrated enhanced virulence when P. aeruginosa was exposed to synthetic (U-50,488) and
endogenous (dynorphin) j-agonists. Using various mutants and reporter strains of P. aeruginosa, we identified
involvement of key elements of the quorum sensing circuitry such as the global transcriptional regulator MvfR and the
quorum sensing-related quinolone signaling molecules PQS, HHQ, and HQNO that respond to j-opioids. The in vivo
significance of j-opioid signaling of P. aeruginosa was demonstrated in mice by showing that dynorphin is released
from the intestinal mucosa following ischemia/reperfusion injury, activates quinolone signaling in P. aeruginosa, and
enhances the virulence of P. aeruginosa against Lactobacillus spp. and Caenorhabditis elegans. Taken together, these
data demonstrate that P. aeruginosa can intercept opioid compounds released during host stress and integrate them
into core elements of quorum sensing circuitry leading to enhanced virulence.
Citation: Zaborina O, Lepine F, Xiao G , Valuckaite V, Chen Y, et al. (2007) Dynorphin activates quorum sensing quinolone signaling in Pseudomonas aeruginosa. PLoS Pathog
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Introduction
It has been suggested for microbial pathogens that colonize
the mucosal surface of a healthy host that symbiosis can be
viewed as a form of molecular de ´tente, a settled negotiation
that is sustained by an ongoing chemical dialogue between
the host and its ﬂora [1]. Even for an opportunistic pathogen,
virulence expression against its host presents a fundamental
tradeoff in that it will provoke immune retaliation and
deplete the host of critical resources, and, as such, bacteria
are constantly assessing the costs versus beneﬁts of express-
ing virulence. Although bacteria use complex systems of
communication like the quorum sensing signaling (QS)
system to collect, process, and share information about the
chemical composition of their environment [2], whether such
events are inﬂuenced by speciﬁc host-derived signals that
indicate a major change in host health status is less well
deﬁned.
Our laboratory has been interested in host-derived
bacterial signaling compounds that are proximate causes of
microbial virulence activation during physiologic stress. To
date, several host-derived bacterial signaling compounds have
been identiﬁed that include adaptive elements of the immune
system such as interferon c [3], tumor necrosis factor a [4],
and interleukin-1 [5], as well as innate elements including
adenosine [6], epinephrine [7–10], and antimicrobial peptides
[11–13]. While in vitro exposure to various host compounds
can activate the virulence of bacteria, much remains to be
learned about how these compounds are collected, processed,
and transduced within the various virulence regulatory
systems of bacteria.
One of the best studied systems of virulence regulation in
bacteria is the QS system. The QS system functions via
autoinducer molecules that are released and taken up by
bacteria to provide a cell–cell communication network
whereby complex assemblage behavior can be carried out
by large populations of bacteria responding to local concen-
trations of QS molecules [2]. In some cases, host-derived
bacterial signaling molecules such as epinephrine have been
shown to act as a surrogate QS autoinducer molecule [8],
activating various virulence genes in intestinal bacteria such
as Escherichia coli. In other cases, the QS system is activated by
the binding of host-derived bacterial signaling molecules to
speciﬁc membrane receptors on the bacteria, such as when
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We considered that opioids might function as host-derived
bacterial signaling molecules given that endogenous opioids
are broadly distributed within the richly innervated intestinal
mucosa and exert multiple effects during stress in neuronal,
immune, and intestinal epithelial cells [14–17]. The intestinal
tract represents a unique intersection of opioids and bacteria
given the high abundance of peripheral neurons, immune
cells, and bacteria in this site. Three main families of opioids
have been identiﬁed based on their afﬁnity to d-, l-, and j-
opioid receptors [14] that include the endogenous opioids b-
endorphin, enkephalin, and dynorphin [18–20]. Following
stress, endogenous opioids have been shown to act as
paracrine and autocrine signals with high levels of functional
redundancy and pleiotropy [21]. These observations, coupled
with the ﬁndings that neutrophils themselves can synthesize
and release opioids at sites of inﬂammation, strongly suggest
that bacteria are exposed to opioids during the course of
infection.
We have been interested in the mechanism by which the
human opportunistic pathogen P. aeruginosa is activated to
express a virulent phenotype during stress. We have
previously shown in mice that stress results in the release of
soluble compounds into the intestinal lumen that directly
activate the virulence of P. aeruginosa to disrupt the intestinal
epithelial barrier [22]. Given the abundance of neurons and
immune cells in the gut that could produce opioids, we
exposed strains of P. aeruginosa to various opioids with
speciﬁcity to l-, k-, and j-opioid receptors and used
pyocyanin (PCN) production as a biologic readout for
virulence expression. Results demonstrated that only the j-
opioid receptor agonist U-50,488 induced PCN production in
a dose-dependent manner. Next, we examined the effect of
dynorphin, a naturally occurring j-opioid peptide known to
be present in the mammalian intestine, on its ability to
produce PCN in P. aeruginosa, and found that dynorphin
potently induced PCN production. In an in vivo stress model
in mice, we demonstrated that dynorphin is released into the
intestinal lumen and binds to desquamated epithelia and
intestinal P. aeruginosa. Dynorphin was found to penetrate the
bacterial membrane and directly induce the expression of the
multiple virulence factor regulator (MvfR)–regulated operon
pqsABCDE, resulting in enhanced production of three known
intercellular QS-related signals, 2-heptyl-4-hydroxyquinoline
N-oxide (HQNO), 4-hydroxy-2-heptylquinoline (HHQ), and
Pseudomonas quinolone signal (3,4-dihydroxy-2-heptylquino-
line [PQS]) [23]. Exposure of P. aeruginosa strain PAO1 to j-
opioid receptor agonists U-50,488 and dynorphin resulted in
enhanced virulence as judged by suppressed growth of the
probiotic microorganisms Lactobacillus spp. and the nematode
Caenorhabditis elegans. Taken together, these studies provide
novel insight into the mechanism by which P. aeruginosa is
activated to express virulence in response to host stress by
processing the opioid peptide dynorphin into its QS
circuitry.
Results
U-50,488 Stimulates P. aeruginosa PAO1 to Produce
Pyocyanin
Preliminary work in our laboratory demonstrated that
exposure of P. aeruginosa to ﬁltered intestinal contents from
stressed mice induced an intensely green color (unpublished
observation), suggesting that the blue-green pigment PCN, a
known quorum sensing–dependent virulence factor [24], was
produced by soluble compounds released into the intestinal
tract during stress. In order to determine whether opioid
compounds might be among the factors responsible for
bacterial virulence activation during stress, we exposed P.
aeruginosa PAO1 to l-, j-, and d-opioid receptor agonists, and
examined bacteria for a change in color and PCN production.
Studies were performed using morphine, a predominately l-
opioid agonist previously shown to be synthesized in animals
[25,26], U-50,488, a speciﬁc synthetic j-opioid, and
BW373U86, a speciﬁc synthetic d-opioid agonist [14]. Figure
1A shows that j-opioid U-50,488 induced an intensely bright
green color in P. aeruginosa PAO1 that correlated to an
increase in PCN production in a dose-dependent manner
(Figure 1B). The d-opioid BW373U86, on the other hand, had
an inhibitory effect on PCN production (Figure 1C), whereas
exposure to the l-agonist morphine resulted in a bell-shaped
type dose response curve for PCN (Figure 1D). Although
exposure to morphine did not increase PCN to the same
degree as with U-50,488 (;40% versus 300%), at lower cell
densities when baseline levels of PCN were negligible, the
effect of morphine appeared to be pronounced at the 50-lM
dose (;600%) (Figure 1E). None of the opioids tested resulted
in signiﬁcant changes in the growth of P. aeruginosa (Figure
1F–1H).
Since PCN production is a quorum sensing–dependent
virulence factor and is produced at high bacterial cell
densities, we analyzed the effect of U-50,488 during bacterial
growth. U-50,488 induced PCN production at earlier cell
density without affecting bacterial growth, suggesting a
regulatory shift in the quorum sensing circuitry of P.
aeruginosa (Figure 1I).
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Author Summary
Precisely how bacterial pathogens such as Pseudomonas aeruginosa
cause fatal infections in critically ill humans is unknown. Evidence
suggests that a major source of infection may be the patient’s own
intestinal microflora, which is subjected to unusual environmental
conditions during critical illness. Here, we show that intestinal P.
aeruginosa can be alerted to the presence of a physiological
disturbance in its host by dynorphin, a human morphine-like
chemical released during severe stress. Exposure of P. aeruginosa to
dynorphin activates its virulence machinery to produce harmful
toxins and to suppress the growth of probiotic bacteria, which are
known to promote intestinal health. The molecular mechanisms of
these events involve the activation of highly regulated virulence
machinery in Pseudomonas, called quorum sensing, that allows
bacteria to sense host stress and respond with enhanced harmful-
ness. These observations suggest that opportunistic pathogens like
P. aeruginosa are equipped with sophisticated surveillance systems
that take advantage of a weakened host by intercepting and
responding to naturally occurring host chemicals that are normally
used as signaling molecules for immune activation and analgesia.
Elucidation of the effect of dynorphin on Pseudomonas exposes a
major mechanism by which this organism behaves as a true
opportunist.PLoS Pathogens | www.plospathogens.org March 2007 | Volume 3 | Issue 3 | e35 0003
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Intact QS System: Role of Proximal QS Regulatory Protein
MvfR in Enhanced PCN Production in Response to U-
50,488
Figure 2A outlines the critical pathways within the QS
system that are involved in the regulation of PCN production.
To verify that j-opioid mediated activation of PCN produc-
tion requires an intact QS system, P. aeruginosa PAO1 mutants
defective in key transcriptional regulators RhlR, LasR, GacA,
and MvfR, as well as the autoinducer synthetases RhlI and
LasI, were exposed to U-50,488 at concentrations of up to 1
mM. All transcriptional regulator mutants failed to produce
PCN both in the presence and absence of U-50,488,
suggesting that an intact QS system is necessary for the j-
opioid–mediated effect (unpublished data). PCN production
was partially restored in DRhlI and DLasI mutants by adding
exogenous C4-HSL (Figure 2B). That the addition of C4-HSL
had a minimal effect in the RhlI mutant can be explained by
competitive binding of 3-oxo-C12-HSL to RhlR in the
absence of C4-HSL. In the double mutant DLasIDRhlI, PCN
production was increased in response to C4-HSL, possibly as
a result of the absence 3-oxo-C12-HS. In contrast to C4-HSL,
the j-opioid agonist U-50,488 failed to restore PCN produc-
tion under the same conditions, suggesting that j-agonists
cannot function as surrogate QS molecules. We next focused
on two key proximal QS regulatory proteins, MvfR and GacA,
Figure 2. Role of Proximal QS Regulatory Protein MvfR in Enhanced PCN Production in Response to U-50,488
Error bars, mean 6 SD.
(A) Schematic of PCN regulation in P. aeruginosa.
(B) PCN production in DRhlI and DLasI mutants exposed to exogenous C4-HSL, 1 mM and U-50,488, 1 mM.
(C) Production of PCN in DMvfR complemented with mvfR (DMvfR/mvfR) and DGacA complemented with gacA (DGacA/gacA) genes on a pUPC24
plasmid, or transformed with blank plasmid (DMvfR/pUCP24, DGacA/pUCP24) in the absence (control) or presence of U-50,488, 1 mM.
(D) Dynamic tracking of PCN production in complemented mutant DMvfR/mvfR grown in the presence of 200 lM U-50,488.
doi:10.1371/journal.ppat.0030035.g002
Figure 1. U-50,488 Induces P. aeruginosa PAO1 to Produce PCN
Error bars are mean 6 SD.
(A) Changes in cell culture color in PAO1 following overnight exposure to 1 mM of j- (U-50,488), d- (BW373U86), and l- (morphine) opioid receptor
agonists.
(B–D) Production of PCN in response to (B) j-agonist U-50,488, (C) d-agonist BW373U86, and (D) l-agonist morphine.
(E) Dose response curve of PCN production in PAO1 exposed to morphine.
(F–H) Effect of opioids on growth of P. aeruginosa PAO1.
(I) Dynamic tracking of PCN production in PAO1 exposed to 200 lM U-50,488.
doi:10.1371/journal.ppat.0030035.g001
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thesis. The mutants were complemented with their respective
genes, mvfR and gacA. While both complemented mutants
produced PCN, responsiveness to the j-agonist U-50,488 was
only observed in DMvfR/mvfR (Figure 2C). Dynamic tracking
of PCN production in the DMvfR/mvfR during growth again
demonstrated enhanced PCN production in response to the
j-agonist (Figure 2D). An inhibitory effect of U-50,488 on
PCN production was found in the complemented DGacA
mutant (Figure 2C). The mechanism for this paradoxical
effect is unknown. It is possible that complex interactions
between the GacA and MvfR regulons that develop in the
presence of high copies of GacA in the complemented
mutant and in MvfR when activated by U-50,488 produce this
dampening effect.
Exposure of P. aeruginosa PAO1 to U-50,488 Results in
Enhanced Expression of pqsABCDE, Production of HQNO,
HHQ, and PQS, and PA-I Lectin Expression
Because MvfR directs the transcription of the pqsABCDE
operon [27], which is responsible for the biosynthesis of 2-
heptyl-4-hydroxyquinoline N-oxide (HQNO) as well as the
direct precursor of the Pseudomonas quinolone signal HHQ
[23], we exposed PAO1 to U-50,488 and examined the effect
of U-50,488 on the expression of pqsABCDE and the
production of HQNO, HHQ, and PQS. The expression of
pqsABCDE was examined by measuring b-galactosidase activ-
ity in strain PAO1 harboring the pGX5 plasmid containing
pqsA’-lacZ construction [28]. Figure 3A shows that exposure of
PAO1 to U-50,488 resulted in enhanced expression of
pqsABCDE. Next, we examined the effect of U-50,488 on mvfR
expression in strain PAO1 harboring the pGX1 containing
the mvfR’-lacZ fusion gene [29] and found that U-50,488 had
no effect on mvfR expression (Figure 3B). The concentrations
of PQS, HHQ, and HQNO were found to be elevated in PAO1
exposed to U-50,488 (Figure 3C). No differences were
observed in the production of other important QS molecules
C4-HSL and 3-oxo-C12-HSL in PAO1 grown in the presence
or absence of U-50,488 (unpublished data). It has been
recently reported that exposure of P. aeruginosa to PQS
signiﬁcantly increases PA-I lectin (PA-IL) expression [30].
Since U-50,488 enhanced PQS biosynthesis, we considered it
might also stimulate PA-IL expression. PA-IL expression was
dynamically tracked in response to U-50,488 using the green
ﬂuorescent PA-IL reporter strain 27853/PLL-EGFP previously
constructed in our laboratory [31]. Marked differences in
ﬂuorescence were observed in this strain during growth in the
absence and presence of U-50,488 (Figure 3D). Results were
conﬁrmed in strain PAO1 by real-time PCR (Figure 3E),
demonstrating the increased expression of the lecA gene
encoding PA-IL following exposure to U-50,488. Expression
of the housekeeping gene gltA encoding citrate synthase was
analyzed under the same conditions, and no effect of U-
50,488 on gltA expression was observed.
The Naturally Occurring j-Opioid Peptide Dynorphin
Enhances the Expression of pqsABCDE, Leading to
Increased Production of HQNO, HHQ, and PQS, the
Expression of phzA1-G1, and Enhanced Biosynthesis of
PCN
Having established that opioid-induced PCN production
in P. aeruginosa is speciﬁc to j-receptor agonists, we next
sought to determine whether naturally occurring endoge-
nous j-agonists could induce PCN production in P.
aeruginosa. Among endogenous opioids, only dynorphin has
been shown to be speciﬁc to the j-receptor [32]. Therefore,
we exposed PAO1 to varying concentrations of dynorphin A
(1–17) (Sigma) and found a dose-dependent effect of
dynorphin on PCN production (Figure 4A). We next
determined if dynorphin increased the expression of mvfR,
pqsABCDE, and phzA1-G1, key components involved in PCN
regulation. The fusion constructs mvfR’-lacZ on pGX1 [23],
pqsA’-lacZ on pGX5 [28], and phzABC-lacZ on MW303 [33]
were introduced into strain PAO1. Similar to U-50,488,
dynorphin did not increase MvfR expression in PAO1/mvfR’-
lacZ (unpublished data); however, dynorphin increased b-
galactosidase activity in both PAO1/phzABS-lacZ (Figure 4B)
and PAO1/pqsA’-lacZ (Figure 4C). When PAO1/pqsA’-lacZ was
exposed to both dynorphin and PQS, b-galactosidase activity
was increased above that observed with either dynorphin or
PQS alone (Figure 4D), suggesting a synergistic effect of
dynorphin and PQS on pqsABCDE expression.
Next, we determined if dynorphin increased pqsABCDE
expression in the absence of PQS. We used a PAO1 derivative
pqsC knockout mutant, strain MP603 [34]. Strain MP603/pqsA’-
lacZ displayed only a baseline level of b-galactosidase activity
both in the presence and absence of dynorphin; however, b-
galactosidase activity was signiﬁcantly increased in response
to the combination of dynorphin and PQS compared to PQS
alone (Figure 4E). The synergistic effect on pqsABCDE
expression in strain MP603 was dependent on the relative
concentrations of dynorphin and PQS. For example, no
synergy was observed when the PQS concentration exceeded
that of dynorphin, and similarly, an inhibitory effect was
observed when the dynorphin concentration (.10-fold)
exceeded that of PQS (unpublished data). Finally, similar to
U-50,488, dynorphin increased HQNO, HHQ, and PQS
production in PAO1 (Figure 4F).
Dynorphin Accumulates in Intestinal Tissues during Stress,
Is Released into the Intestinal Lumen, and Is Transferred to
Bacteria within the Intestinal Lumen
We hypothesized that bacteria might be exposed to
dynorphin in vivo in the intestinal tract under clinically
relevant pathophysiological conditions [35]. To test this, we
exposed the mouse intestine to two conditions: 1) 30 min of
ischemia followed by 30 min of reperfusion stress, and 2)
ischemia/reperfusion (I/R) stress coupled with luminal inoc-
ulation with P. aeruginosa (I/RþPa). Figure 5A–5C shows 4-lm
intestinal sections isolated from (A) control, (B) I/R, and (C) I/
R þ Pa mice, and stained with hematoxylin and eosin. The
black arrows on Figure 5B and 5C show desquamated
epithelium that is a common feature of this injury. Figure
5D–5G shows immunohistochemical staining of intestinal
segments for dynorphin. In control samples (Figure 5D and
5G), dynorphin was found to be scarcely localized to the
crypts (Figure 5D, red arrow), whereas following I/R injury,
dynorphin was found to be abundantly present on the villus
tips and within the intestinal lumen (Figure 5E and 5H, red
arrows), a ﬁnding that appeared to be enhanced in the
presence of luminal P. aeruginosa (Figure 5F and 5I, red
arrows). Examination of bacteria within the intestinal lumen
and on the epithelial surface demonstrated positive dynor-
PLoS Pathogens | www.plospathogens.org March 2007 | Volume 3 | Issue 3 | e35 0005
Dynorphin Induces P. aeruginosa Virulencephin staining bacteria at various sites, including bacteria
attached to intestinal epithelial cells (Figure 5J–5M).
To determine the concentration of dynorphin in the
luminal contents of intestinal segments subjected to I/R and
I/RþPa, 10-cm segments were ﬂushed with 2 ml of phosphate
buffered saline (PBS) containing protease inhibitor cocktail
(Roche), and samples assayed using competitive enzyme-
linked immunosorbent assay (ELISA). Figure 5N shows a
signiﬁcant increase in luminal dynorphin in mice subjected
to I/R injury that was further increased when I/R was coupled
Figure 3. U-50,488 Induces pqsABCDE Expression, Biosynthesis of HQNO, HHQ, and PQS, and Stimulates PA-IL Expression
Error bars, mean 6 SD.
(A) Effect of U-50,488, 200 lM and PQS, 100 lMo npqsA’-lacZ expression in P. aeruginosa strain PAO1/pGX5 following 5 h of incubation.
(B) Effect of U-50,488, 200 lM and PQS, 100 lMo nmvfR’-lacZ expression in P. aeruginosa strain PAO1/pGX1 following 5 h of incubation.
(C) Effect of U-50,488, 200 lM on HQNO, HHQ, and PQS production by P. aeruginosa PAO1. * p , 0.01.
(D) Dynamic tracking of PA-IL expression using PA-IL reporter strain P. aeruginosa 27853/PLL-EGFP.
(E) Real-time PCR of lecA encoding PA-IL and the housekeeping gene gltA encoding citrate synthase in P. aeruginosa PAO1 grown to OD600nm¼3.0 in
the presence of 200 lM of U-50,488. The graph was made based on the Ct levels for gltA, 20.2660.81 (control) versus 20.7860.26 (U-50,488); and for
lecA, 29.5360.43 (control) versus 27.4260.97 (U-50,488). Ct levels for lecA blank control (no template) were ; 40.
doi:10.1371/journal.ppat.0030035.g003
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deﬁne the putative role of dynorphin on PCN production in
vivo, PAO1 was exposed to ﬁltered (0.22 lm) luminal contents
from each group of mice, and PCN production determined.
Exposure of PAO1 to luminal ﬂushings from intestinal
segments of the various groups of mice demonstrated a
signiﬁcant correlation between dynorphin concentration in
the luminal samples and its ability to induce PCN production
(R ¼ 0.7987, Figure 5O). Immunodepletion of dynorphin in
samples using rabbit polyclonal anti-dynorphin antibody
attenuated the ability of samples to induce PCN production
in PAO1 (Figure 5P).
Dynorphin Binds to P. aeruginosa In Vitro and Enters the
Bacterial Cytoplasm
To conﬁrm that dynorphin can bind to bacteria, we
performed in vitro staining of P. aeruginosa in the presence
of dynorphin. Dynorphin (100 lM) was added to P. aeruginosa
at the early log phase, and incubated for 1 h. Cells were
collected, washed, and ﬁxed on slide. Dynorphin was detected
by immunostaining using anti-dynorphin pAB. Figures 6A
and 6B show negative dynorphin staining in the negative
controls when cells were cultivated without dynorphin (A),
and when cells were cultivated with dynorphin but primary
antibodies were omitted and rabbit serum was used instead
(B). Figure 6C demonstrates positive dynorphin staining in
cells cultivated with dynorphin followed by treatment with
anti-dynorphin antibody. Structurally, dynorphin is similar to
other cell-penetrating peptides in that its high content of
basic and hydrophobic amino acid residues facilitates its
penetration through mammalian cell membranes [36]. There-
fore, by using immunogold electron microscopy, we deter-
mined the ability of dynorphin to traverse the bacterial
Figure 4. Dynorphin Activates MvfR-Dependent Pathway in P. aeruginosa PAO1
Error bars, mean 6 SD.
(A) Dose-dependent effect of dynorphin on PCN production.
(B) Expression of phzC1-lacZ in PAO1/pMW303 in the absence (control) or presence of 100 lM of dynorphin.
(C) Dynamic tracking of expression of pqsA’-lacZ in PAO1/pGX5 grown in the presence of dynorphin, 100 lM, or PQS, 100 lM.
(D) Expression of pqsA’-lacZ in PAO1/pGX5 in response to dynorphin, 100 lM, or PQS, 100 lM, or dynorphin plus PQS (100 lM each) determined after 5
h of incubation.
(E) Expression of pqsA’-lacZ in MP603/pGX5 in response to dynorphin, 100 lM, or PQS (20 and 80 lM), or sum of dynorphin (100 lM) and PQS (20 lM);
or sum of dynorphin (100 lM) and PQS (80 lM) determined after 5 h of incubation.
(F) Concentration of HQNO, HHQ, and PQS in P. aeruginosa PAO1 after 8 h of growth in the absence (control) or presence of dynorphin, 100 lM.
doi:10.1371/journal.ppat.0030035.g004
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Dynorphin Induces P. aeruginosa VirulenceFigure 5. In Vivo Production of Dynorphin in the Mouse Intestine during I/R
(A–C) Histology of small intestine from (A) control mice demonstrating intact mucosal epithelium, and (B) I/R and (C) I/RþPa mice showing disruption
of mucosal epithelium with desquamated epithelial cells inside the intestinal lumen (black arrows).
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Dynorphin Induces P. aeruginosa Virulenceplasma membrane and enter the bacterial cell interior. Figure
6D shows an image of P. aeruginosa PAO1 cells incubated with
dynorphin. Localization of dynorphin was identiﬁed by 10-
nm gold particles (black arrows), which were found predom-
inantly in the bacterial cytosol fraction close to the inner
membrane.
j-Opioid Receptor Agonists U-50,488 and Dynorphin
Enhance the Virulence of P. aeruginosa PAO1 against
Lactobacillus and C. elegans
To determine the clinical relevance of the above ﬁndings,
we examined the ability of j-opioid receptor agonists to shift
the virulence of P. aeruginosa against the nematode C. elegans.
(D–F, G–I) Immunohistochemistry of the small intestine from (D and G) control mice demonstrating scarce dynorphin localized to the epithelial crypt
(brown staining, red arrow), and following (E and H) I/R and (F and I) I/RþPa showing dynorphin migration up the lamina propria (red arrows, [E]) and
its accumulation on villi and within the lumen. Scale bars are in lm.
(J–M) Images of luminal bacteria from mouse small intestine subjected to I/RþPa demonstrating (J) transfer of dynorphin to bacteria (brown-colored
bacteria) and (K) positive dynorphin stained bacteria bound to desquamated epithelia; (I) abundant epithelial dynorphin staining (red arrow), and (M)
co-localization of dynorphin stained luminal bacteria to sites of dynorphin accumulation at the epithelial surface. Scale bars are in lm.
(N) Concentration of dynorphin in filtered luminal flushes isolated from intestine of control mice and mice subjected to I/R and I/RþPa. n¼10/group, *
p ,0.001.
(O) Correlation analysis between dynorphin concentration in luminal flushes and their ability to induce PCN production in PAO1.
(P) Effect of dynorphin depletion with anti-dynorphin antibody on the ability of luminal flush samples to produce PCN in PAO1, n¼6/group, * p ,0.005.
Error bars, mean 6 SD.
doi:10.1371/journal.ppat.0030035.g005
Figure 6. Dynorphin Binds to P. aeruginosa In Vitro, and Enters the Bacterial Cell Cytoplasm
(A–C) Binding of dynorphin to P. aeruginosa; (A) negative control demonstrating no dynorphin staining when cells were not incubated with dynorphin;
(B) negative control demonstrating no dynorphin staining when cell were incubated with dynorphin but primary anti-dynorphin antibodies were
omitted from staining procedure; and (C) positive staining (brown color) of P. aeruginosa incubated with dynorphin followed by whole procedure of
immunostaining.
(D) Immunoelectron microscopy of P. aeruginosa PAO1 cells incubated with dynorphin, 100 lM. Black arrows show 10-nm gold spots indicating the
presence of dynorphin.
doi:10.1371/journal.ppat.0030035.g006
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j-opioid receptor agonists could affect the growth of the
cytoprotective probiotic organisms Lactobacillus plantarum and
Lactobacillus rhamnosus [37–40]. Media from P. aeruginosa PAO1
grown in the presence of U-50,488 suppressed the growth of
L. plantarum and L. rhamnosus GG (Figure 7A and 7B), whereas
U-50,488 alone had no effect (unpublished data). Similarly,
media from P. aeruginosa PAO1 grown in the presence of
dynorphin suppressed the growth of Lactobacillus, whereas
dynorphin alone had no effect (Figure 7C and 7D).
Conditioned media from the PAO1 DMvfR mutant grown in
the presence or absence of dynorphin did not affect the
growth of Lactobacillus spp., suggesting that the j-mediated
effect is regulated via MvfR (Figure 7E). C. elegans feeding on
lawns of PAO1 exposed to U-50,488 or dynorphin demon-
strated suppressed production of new progeny, an indicator
of enhanced virulence (Figure 7F and 7G). In this assay, the
PAO1 DMvfR mutant was observed to be signiﬁcantly less
virulent compared to the wild-type PAO1 (Figure 7F), and its
virulence was not enhanced in the presence of j-agonists
(Figure 7F and 7G).
Discussion
In animals exposed to physiologic or traumatic stress,
subsequent bacterial challenge has been shown to result in
increased mortality [10,31] in association with impaired
immune function and bacterial clearance [17,41,42]. Data
from the present study add to the small but expanding body
of data showing that soluble compounds released by the host
during stress and immune activation can directly interact
with pathways of bacterial virulence regulation in a highly
Figure 7. j-Opioid Receptor Agonists Activate Virulence of P. aeruginosa against Probiotic Bacteria and C. elegans
Error bars, mean 6 SD.
(A and B) The exposure of P. aeruginosa PAO1 to U-50,488, 200 lM, increases the inhibiting effect of its extracellular milieu (conditioned media) on the
growth of probiotic microorganisms (A) L. plantarum and (B) L. rhamnosus GG.
(C and D) The exposure of P. aeruginosa PAO1 to dynorphin, 100 lM, increases the inhibiting effect of its extracellular milieu (conditioned media) on the
growth of probiotic microorganisms (C) L. plantarum and (D) L. rhamnosus GG.
(E) The extracellular milieu of P. aeruginosa PAO1 mutant DMvfR exposed to dynorphin, 100 lM, did not inhibit the growth of probiotic microorganism
L. rhamnosus GG.
(F and G) P. aeruginosa PAO1 but not mutant DMvfR exposed to (F) U-50,488, 200 lM, or (G) dynorphin, 100 lM, suppressed the production of new
progeny in C. elegans.
doi:10.1371/journal.ppat.0030035.g007
PLoS Pathogens | www.plospathogens.org March 2007 | Volume 3 | Issue 3 | e35 0010
Dynorphin Induces P. aeruginosa Virulencespeciﬁc manner [3,8,11]. Opioids are ubiquitous neuro-
transmitters within the enteric nervous system and encom-
pass a wide variety of functions, including motility, secretion,
immune modulation, and maintenance of epithelial barrier
function. The abundance of the neural network within the
intestinal tract is matched only by its microbial ﬂora, where
bacterial cells outnumber the total number of cells in the
body [14]. In this study, we found j-opioid receptor agonists
to induce PCN production in P. aeruginosa.A l t h o u g h
dynorphin has been shown to be present in a variety of
tissues, whether dynorphin accumulates in intestinal tissues
following host stress and/or bacterial infection has not been
previously addressed. Data from the present study show for
the ﬁrst time to our knowledge, that dynorphin is released
into the intestinal lumen following I/R injury and accumulates
in regions of high dynorphin concentration, such as on
desquamated epithelium, where it binds to P. aeruginosa.
Binding of dynorphin to P. aeruginosa was further conﬁrmed
in vitro by direct antibody staining. In addition, the
penetration of dynorphin into the cytosolic compartment
of bacterial cells was demonstrated by immunoelectron
microscopy. These ﬁndings, coupled with the observation
that dynorphin can activate the virulence of P. aeruginosa, may
be of signiﬁcant clinical relevance given that intestinal
ischemia invariably accompanies physiologic stress and has
been associated with fatal infection due to intestinal P.
aeruginosa [43,44]. However, dynorphin may enhance the
virulence of P. aeruginosa not only within the intestine but
also at other sites of tissue injury and inﬂammation. There is
overwhelming evidence that opioids are released and
accumulate at sites of inﬂammation primarily because all of
these tissues sites are heavily innervated and highly populated
by macrophages and neutrophils. [45,46]. The ubiquitous
presence of opioid receptors on nerves throughout the body
suggests that exposure of P. aeruginosa to opioids may be one
of the reasons it has evolved a mechanism to respond to these
compounds [45,46]. Therefore, P. aeruginosa virulence could
be activated by dynorphin in all infections associated with
inﬂammation, including burns, implanted medical devices,
and lung infections in patients with underlying lung disease.
The precise mechanisms by which colonizing pathogens
important to human disease process host signals for the
purposes of virulence activation is a small and poorly
understood area of investigation. The pathways by which
bacteria gather, process, and become activated by host signals
have been shown to be both speciﬁc to bacteria and speciﬁc
to the host signal involved, and gene activation through the
QS system has been previously reported [3,8]. A major
mechanism by which the j-opioid receptor agonists U-
50,488 and dynorphin affect virulence gene activation in P.
aeruginosa could be via expression of the pqsABCDE operon.
The pqsABCDE operon directs the biosynthesis of 4-hydroxy-
Figure 8. Proposed Activation and Effectors Pathways of P. aeruginosa in Response to Host Stress (Intestinal I/R Injury)
(1) Dynorphin is released by intestinal tissues and accumulates in the lumen during ischemia/reperfusion and penetrates the plasma membrane of P.
aeruginosa (dark green arrows).
(2) Dynorphin synergizes with PQS via MvfR to increase the transcription of pqsABCDE leading to the production of HAQs, including HQNO and HHQ.
(3) Increased HQNO production suppresses the growth of Lactobacillius spp., rendering the intestinal epithelium more vulnerable to invasion and the
action of cytotoxins of P. aeruginosa (red arrows).
(4) HHQ is the immediate precursor of PQS [23], and both compounds play an important role in bacterial cell-to-cell communication [23] (yellow and
blue arrows).
(5) PQS induces the expression of pqsABCDE [63], and is required for phzA1-G1expression, the gene responsible for PCN production (blue arrows). 6.) The
release of PCN can induce neutrophils apoptosis and damage epithelial cells [64] (green arrows) allowing for immuno-evasion and deeper penetration
of bacteria.
doi:10.1371/journal.ppat.0030035.g008
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themselves signaling molecules. Additionally, HHQ is a direct
precursor of PQS [23]. PQS functions as a regulatory link
between the LasRI and RhlRI quorum sensing systems [30,47],
and has been shown to play a critical role in the pathogenesis
of P. aeruginosa in nematodes, plants, and mice [24,48,49]. Data
from the present study suggest that dynorphin synergizes
with PQS to increase pqsABCDE expression. Further experi-
ments are underway to clarify the precise mechanism of
dynorphin activation of pqsABCDE expression.
Among critically ill and immunocompromised patients,
infection with P. aeruginosa carries the highest case fatality
rate of all nosocomial pathogens, approaching 60% [50,51].
The primary site of colonization for P. aeruginosa in such
patients is the gastrointestinal tract, where as many as 50% of
hospitalized patients harbor this organism [52,53]. Risk
factors for mortality due to P. aeruginosa infection suggest
that the degree of host stress is a major determinant of a fatal
outcome from this pathogen [53,54]. In the present work we
show (Figure 8) that P. aeruginosa presents a ‘‘triple threat’’ to
its host when exposed to dynorphin in that it can 1) activate
QS circuits via enhanced PQS production, 2) reduce
populations of protective probiotic bacteria such as lactoba-
cilli through the production of HQNO and PCN [55], and 3)
increase the production of QS-dependent virulence gene
products that affect host cell function such as PCN and the
PA-I lectin/adhesin [30,56–58]. A clearer understanding of the
mechanisms by which P. aeruginosa is activated to express
virulence in direct response to host stress has the potential to
lead to preventive therapies that interdict in the process of
infection at its most proximate point.
Materials and Methods
Bacterial strains and culture conditions. P. aeruginosa strain PAO1
and its derivatives were routinely grown in tryptic soy broth (TSB)
supplemented when necessary with tetracycline (Tc), 60 lg/ml,
gentamicin (Gm), 100 lg/ml, or carbenicillin (Cb), 300 lg/ml. P.
aeruginosa strains PAO1 wild-type, DRhlR (rhlR:: ISphoA/hah, ID
44488), and DMvfR (mvfR:: ISlacZ/hah, ID 13375) were obtained from
the P. aeruginosa mutant library [59]. Strains PAO-R1 (DLasR
(lasR::Tc), PAO-JP-1 (DLasI (lasI::Tc), and PDO100 (DRhlI (rhlI::Tn501)
were kindly provided by B. Iglewski. Strains PAO6281 (DGacA
(gacA::Spr /Sm), PAO-MW1 (DRhlIDLasI (rhlI::Tn501 lasI::tetA), and
MP603 (pqsC::Tc) were kindly provided by C. Reimmann, P. Green-
berg, and C. Manoil, respectively.
PCN assay. P. aeruginosa cultures were grown at 37 8C, under
shaking conditions at 220 rpm, in TSB supplemented with either
morphine (Abbott Laboratories, http://www.abbott.com), U-50,488
(Sigma, http://www.sigmaaldrich.com), or BW373U86 (Sigma) at
varying concentrations. Following overnight incubation, bacterial
cells were spun down by centrifugation at 10,000g for 5 min, and 1 ml
of supernatant was extracted using 500 ll of chloroform, re-extracted
with 150 ll of 0.2 M HCl, and then PCN was measured at OD 520 nm
as described [60]. In experiments with dynorphin A (1–17) (Sigma),
200 ll of bacterial culture was incubated in 2-ml wells of a 96-well
microplate (Whatman, http://www.whatman.com). Following over-
night incubation, 200 ll of chloroform and 150 ll of 0.2 M HCl
were used to extract PCN from cell-free culture media. In dynamic
experiments, PAO1 was grown in TSB supplemented with 200 lMU -
50,488, and 1-ml aliquots were serially collected. Cell density was
measured at OD 600 nm, and samples were processed for PCN assay.
In experiments in which strains complemented with mvfR or gacA on
the pUCP24 plasmid were used, experiments were performed with a
higher dose of U-50,488 (1 mM), as a baseline of PCN production was
already high due to these strains containing multi-copy plasmids
encoding MvfR or GacA.
The b-galactosidase assay. Plasmid pGX5 [28] harboring the pqsA’-
lacZ fusion construction was introduced in P. aeruginosa strains PAO1
and MP603; and plasmids pGX1 harboring the mvfR’-lacZ fusion [23]
and pMW303 harboring the phzABC-lacZ fusion [33] were introduced
in PAO1 by electroporation. Single colonies of PAO1/pGX5 or PAO1/
pGX1, or PAO1/pMW303 were used to inoculate TSB supplemented
with carbenicillin (Cb), 300 lg/ml, for overnight growth at 37 8C, 220
rpm. Overnight culture was diluted 1:100 in TSB, and 300 lg/ml Cb
was supplemented with U-50,488, 200 lM, or dynorphin, 100 lM, or
PQS, 100 lM, or without supplementation (control). Aliquots of cells
cultures were taken out dynamically; pellet was collected by
centrifugation at 6,000g, 5 min, and kept at  808C before processing.
MP603/pGX5 was inoculated in TSB supplemented with Tc, 60 lg/ml
and Cb, 300 lg/ml. Overnight cultures were diluted 1:100 in TSB,
subgrown for 1 h to a cell density of OD600nm 0.07–0.1, and aliquoted
to create the following groups (in triplicates): 1) ‘‘control’’,2 )
‘‘dynorphin’’, dynorphin added to a ﬁnal concentration of 100 lM;
3) ‘‘PQS’’, PQS added to ﬁnal concentrations of 20 and 80 lM; and 4)
‘‘dynorphinþPQS’’, dynorphin added to a ﬁnal concentration of 100
lM, incubated for 1 h, followed by the addition of PQS to a ﬁnal
concentration of 20 and 80 lM. All cell cultures were collected at the
same time (5 h), cell density of 1:10 dilutes samples was measured at
OD 600 nm, and cells were collected by centrifugation at 6,000g, 5
min, and kept at 808C before processing. For b-galactosidase activity
analysis, cells were treated with protein extraction reagent (Bug-
Buster Master Mix; Novagen, http://www.emdbiosciences.com/html/
NVG/home.html) for 20 min at room temperature, centrifuged for 30
min at 4 8C, and cytosol fractions were used to measure b-
galactosidase activity. In this case, 15 ll of cytosol fractions were
loaded on 96-well plates, followed by 135 ll of a master mixture of o-
nitrophenyl-b-D-galactopyranoside (ONPG, Sigma) containing 100 ll
of 0.1 M Na-phosphate buffer (pH 7.5), 33 ll of ONPG, 4 mg/ml
dissolved in 0.1 M Na-phosphate buffer (pH 7.5), and 2 ll of Mg buffer
(63 ll of H2O, 35 ll of 2-mercaptoethanol, and 2 ll of 5 M MgCl2).
Absorbance at 410 nm was measured using Plate Reader, and results
were expressed as Miller units (1,000 3 D410 nm 3 mg protein
 1 3
min
 1).
RNA isolation and cDNA synthesis. For RNA isolation, 1 ml of P.
aeruginosa PAO1 culture was grown in TSB with or without 200 lMU -
50,488, to OD600 nm¼3.0. Next, 2 ml of RNA Protect Bacteria reagent
(Qiagen, http://www1.qiagen.com) was added immediately at the end
of the incubation period, and samples treated as recommended by
the Qiagen’s lysis protocol, followed by the addition of 3 ml of TRIzol
LS reagent (Invitrogen, http://www.invitrogen.com). The RNA enrich-
ment fraction was separated using Phase lock gel, heavy (Eppendorf,
http://www.eppendorf.com). RNA was precipitated with isopropanol,
dissolved in water, and the remaining DNA degraded using DNA-Free
kit (Ambion, http://www.ambion.com). RNA integrity was monitored
by formaldehyde agarose gel electrophoresis, and the absence of DNA
checked by PCR using primers for 16S r RNA, forward 59-
GGACGGGTGAGTAATGCCTA-39 and reverse 59-CGTAAGGGC-
CATGATGACTT-39. The ﬁrst-strand cDNA was prepared using 2
lg of total RNA, Superscript II RNase H–RT (Invitrogen), and
random primers as recommended by the manufacturer’s protocol.
Real-time reverse transcription (RT)–PCR. Real-time PCR was
performed on the ABI Prizm 7300 Sequence Detection System using
SYBR Green qPCR SuperMix-UDG (Invitrogen), cDNA, and respec-
tive primers: for gltA encoding citrate synthase (PA1580),
5 9TCTACCACGACTCCCTGGAC39 and
59TTTTCCGCGTAGTTCAGGTC39;f o rlecA encoding PA-IL
(PA2570), 59CGATGTCATTACCATCGTCG39 and
59ACCCTGGACATTATTGGGTG39. The integrity of the RT-PCR
products was conﬁrmed by melting-curve analysis. Expression levels
were calculated based on differences in Ct levels.
Protein concentration assay. Protein was measured using the BCA
Protein Assay Reagent (Pierce, http://www.piercenet.com).
HQNO, HHQ, and PQS quantiﬁcation. A single colony of PAO1
was used to inoculate 5 ml of TSB. Overnight culture was diluted in
fresh TSB at 1:100, supplemented with either U-50,488 (200 lM) or
dynorphin (100 lM). After 20 min of incubation under shaking
conditions, cell cultures were aliquoted as 650 ll in 14-ml culture
tubes. At designed time points, three tubes from each group were
removed, and 650 ll of MeOH containing 2% acetic acid was
immediately added, properly mixed, replaced into Eppendorf tubes,
centrifuged at 13,000g, 30 min, 4 8C, and the supernatant used to
quantify HQNO, HHQ, and PQS by HPLC/MS according to Le ´pine et
al. [61]. Unlabeled PQS was obtained by the same synthetic route
described for deuterium-labeled PQS [61]. The ﬁnal PQS-d4
concentration was 20 mg/l, and the stock solutions were in methanol.
C4-HSL and 3-oxo-C12-HSL quantiﬁcation. The homoserine
lactones were quantitated by LC/MS/MS using a water/acetonitrile
gradient containing 1% acetic acid. The analyses were performed in
positive electrospray ionization mode and the acquisitions were
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monitored were m/z 298 to 102 for the N-(3-oxododecyl)-homoserine
lactone and m/z 172 to 102 for the N-(butyroyl)-homoserine lactone.
Argon at 2.0 3 10
 3 mtorr was the collision gas and the collision
energy was 15 eV.
Complementation of MvfR mutant with mvfR gene. The mvfR gene
was ampliﬁed using primers forward 59-AAGGAATAAGGGATGCC-
TATTCA-39 and reverse 59-CTACTCTGGTGCGGCGCGCTGGC-39
and cloned in pCR2.1 (Invitrogen). Plasmid pCR2.1/mvfR was digested
with XbaI-HindIII restrictases, and mvfR was subcloned in pUCP24
under the Plac promoter [62] to create pUCP24/mvfR. The plasmids
pUCP24 and pUCP24/mvfR were electroporated in strain 13375
defective in MvfR production to create strains DMvfR/pUCP24
(control) and DMvfR/mvfR .
Complementation of GacA mutant with gacA gene. The gacA gene
was ampliﬁed using primers forward 59-CGACGAGGTGCAGCGT-
GATTAAGGT-39 and reverse 59-CTAGCTGGCGGCATCGAC-
CATGC-39 and cloned in pCR2.1 (Invitrogen). Plasmid pCR2.1/gacA
was digested with XbaI-HindIII restrictases, and gacA was subcloned
in pUCP24 under the Plac promoter to create pUCP24/gacA. The
plasmids pUCP24 and pUCP24/gacA were electroporated in strain
PAO6281 defective in GacA production to create strains DGacA/
pUCP24 and DGacA/gacA.
Anti-MvfR antibody. Polyclonal antiserum against 50–63 peptide
LVRRDGYKVEPTEQ of PA1003 (MvfR) was produced in rabbits
(ZYMED Laboratories, http://www.invitrogen.com). Anti-MvfR anti-
bodies were afﬁnity puriﬁed by AminoLink Plus Immobilization Kit
(Pierce) using 50–63 peptide to create an afﬁnity column.
Segmental intestinal I/R model. All experiments on mice were
performed in accordance with University of Chicago guidelines and
regulations, and mouse protocol number 71629 was approved by the
Animal Care and Use Committee of the University of Chicago. Male,
wild-type C57Bl/6 mice (8- to 10–wk-old; Charles River, http://www.
criver.com) were fasted overnight prior to use in the I/R studies. For
these studies, mice were lightly anesthetized with sevoﬂurane prior to
an i.p. bolus injection of Avertin (Sigma-Aldrich #T4, 840–2)
prepared as a 1.2 % solution, at 0.2 ml 3 10 g
 1 body weight. Mice
were placed on a warmed heating pad under a warming light. An
abdominal midline incision was made and the small intestines
exposed. Sutures were placed so as to isolate a 20-cm segment of
small intestine. The intestine was divided proximally and distally
using cautery. A clamp was placed on the superior mesenteric artery
(SMA) to occlude blood ﬂow to the jejunum and ileum. Ischemia was
conﬁrmed by visible blanching of the intestinal segment. During the
ischemic and reperfusion period, mice were hydrated via i.p.
administration of warmed saline. After 30 min of ischemia, the
SMA clamp was removed and the intestinal tract allowed to reperfuse
for 30 min prior to removal of the isolated segment. This segment was
then immediately ﬂushed with 2 ml of PBS containing a protease
inhibitor cocktail (Roche, http://www.roche.com). Mice were euthan-
ized by an overdose of anesthesia, followed by cervical dislocation. In
selected experiments, P. aeruginosa (Pa) was injected into the isolated
intestinal segment prior to SMA clamping at a concentration of 10
7
CFU/ml in 2 ml of PBS to recapitulate the clinical circumstance of I/R
occurring in the presence of an opportunistic infection (I/R þ Pa).
Histological and immunohistochemical staining. For histology,
specimens were ﬁxed in 10% buffered formalin and embedded in
parafﬁn. Parafﬁn specimens were cut into 4-lm sections and were
mounted on micro slides. Hematoxylin and eosin–stained slides were
then reviewed using an Olympus microscope. For immunohisto-
chemical staining, sections were deparafﬁnized and re-hydrated
through xylen and serial dilutions of ETOH to distilled water.
Section were then incubated in antigen retrieval buffer (DAKO,
S1699; http://www.dako.com) and heated in a steamer at 98 8C degree
for 20 min. After rinsing, slides were incubated in 3% hydrogen
peroxide for 5 min and then 10% normal goat serum in 0.025%
Triton X-100-PBS for 30 min. Anti-dynorphin A (1–17) antibody
(EMD Biosciences, http://www.emdbiosciences.com) at 1:25 dilution
was applied for overnight incubation at 4 8C in a humidity chamber.
Following a TBS wash, slides were incubated with secondary antibody
(DAKO, K4011) and the antigen–antibody binding was detected by
DAB substrate chromogen system (DAKO, K3466). To ensure that
positive staining was speciﬁc, control experiments were performed as
outlined above, eliminating the primary antibodies, and showed no
staining. Slides were brieﬂy immersed in hematoxylin for counter-
staining and evaluated under Zeiss Axioskop (http://www.zeiss.com),
using oil 253Korr objective na 1.3 and oil 633apochromat objective
na 1.4 with pixel sizes 1280 3 1024 regular and 3840 3 3072 highest.
In vitro immunostaining of P. aeruginosa PAO1 incubated with
dynorphin. Cells of P. aeruginosa were grown overnight in TSB and
diluted 1:100 with 400 ll of fresh TSB media. After 2 h of incubation,
cells were added by dynorphin, 100 lM (when needed), and incubated
for one more hour. Cells were collected, washed three times with PBS,
and ﬁxed in 4% paraformaldehyde for 2 h, 4 8C, at rotation. Then,
cells were kept on ice for 45 min followed by intensive washing with
PBS. After last washing, cells were resuspended in 200 ll of PBS, and
100 ll of cell suspension was poured on slide. The ﬁxation of cells to
slide was allowed overnight at room temperature. Cells on slides were
then incubated in antigen retrieval buffer (DAKO, K4011) and
followed the above procedure of immunostaining (see ‘‘Histological
and immunohistochemical staining’’). Two negative controls were
performed: 1) omitting dynorphin, and 2) omitting primary anti-
dynorphin antibodies.
Immunoelectron microscopy. P. aeruginosa PAO1 was grown for 10
h in the presence of dynorphin, 100 lM, and then cells collected by
centrifugation, 5,000g, 5 min, washed with PBS, and ﬁxed with 4%
paraformaldehyde plus 0.1% glutaraldehyde in 0.1 M phosphate
buffer (pH 7.4) (PB) for 1 h. After ﬁxation, cells were washed with 0.1
M PB, and gradually dehydrated using ethanol at increasing
concentrations from 30% to 100%. Inﬁltration was performed using
100% ethanol:LR White Medium (Electron Microscopy Sciences
http://www.emsdiasum.com/microscopy) (1:1) for 1 h followed by
overnight inﬁltration with LR White Medium. After inﬁltration, cells
were embedded in gelatin capsules. Polymerization was performed in
a vacuum oven at 45 8C for 48 h. Then, 80-nm thickness sections were
cut using a Reichert-Jung Ultracut E, and mounted on formvar-
coated 200-mesh nickel grids. Sections on grids were re-hydrated with
PBS for 30 min, blocked with 1% BSA in PBS for 30 min, and primed
with rabbit anti-dynorphin A 1–17 antibody (EMD Biosciences) at
1:25 dilution in 1% BSA at humidiﬁed chamber for 3.5 h. Grids were
extensively washed with PBS, blocked with 0.1% BSA in PBS for 25
min, and incubated in a humidiﬁed chamber for 1 h with goat anti-
rabbit IgG conjugated with 10-nm gold particles (Ted Pella, http://
www.tedpella.com) at 1:10 dilution in 0.1% BSA. Grids were washed
with PBS, ﬁxed with 1% glutaraldehyde in PBS for 10 min, washed
with water, and stained brieﬂy with uranyl acetate and lead citrate.
Air dried grids were examined at 300 kV with an FEI Tecnai F30 (FEI,
http://www.fei.com). Two negative controls were used: 1) grids without
incubation with rabbit anti-dynorphin A 1–17 antibody, and 2) PAO1
grown in the absence of dynorphin.
Biotinylation of dynorphin. Dynorphin A (1–17) (Sigma) was
biotinylated using NHS-PEO4-biotin (Pierce), and puriﬁed by HPLC.
Competitive ELISA for detection dynorphin in luminal ﬂushings.
Luminal ﬂushings were ﬁltered with 0.22-lm ﬁlters (Millipore, http://
www.millipore.com), aliquoted, and stored at 80 8C. Afﬁnity puriﬁed
F(ab)2 of Frag Donk anti-Rb IgG (Jackson Immunological Research
Laboratories, http://www.jax.org) at a concentration of 10 lg/ml in
carbonate-bicarbonate buffer (Sigma) were coated onto Maxisorp
immunomodules (Nunc, http://www.nuncbrand.com) for 2 h at 37 8C.
Unbound sites were blocked with 3% bovine serum albumin in PBS
for 30 min at room temperature. After blocking, rabbit anti-
dynorphin A (1–17) antibodies (EMD Biosciences) at 1:250 dilution
in PBST (PBS, Tween 0.05%) were added to wells for 1 h, at 37 8C.
After washing with PBST, mixtures of biotinylated dynorphin, 50 ng/
ml with varying concentrations of unlabeled dynorphin (0, 20, 50, 100
ng/ml) or ﬁltered luminal ﬂushings diluted in buffer (20 mM
phosphate buffer (pH 7.4), 150 mM NaCl, 10 mM EDTA, 0.5% BSA,
0.02% Triton X-100) were loaded for 2 h at 37 8C. In this manner
biotinylated dynorphin competes for antibody binding sites with
unlabeled dynorphin or dynorphin in luminal ﬂushes. After
incubation, unbound biotinylated peptide was removed by washing
with PBST, and ImmunoPure streptavidin-conjugated horseradish
peroxidase (Pierce) was added and allowed to bind to the
immobilized primary antibody-biotinylated peptide complex. After
washing, O-phenylaminediamine (Sigma) was allowed to react with
the bound HRP. The color intensity that develops is dependent on
the quantity of biotinylated peptide bound to the immobilized
antibody. When more non-biotinylated peptide competes for the
limited amount of antibody, less biotinylated peptide/SA-HRP can be
immobilized and less color is produced by the substrate
PCN assay in PAO1 induced by luminal ﬂushings. PAO1 was
exposed to 20 ll of 0.22 lm-ﬁltered luminal ﬂushings included in 2 ml
of TSB, and PCN was measured after overnight growth. For
immunodepletion, samples were pre-incubated with anti-dynorphin
antibody (EMD Biosciences) at 1:100 dilution for 2 h.
Effect of conditioned media from P. aeruginosa on the growth of
Lactobacillus spp. Overnight cultures of P. aeruginosa PAO1 were used
to inoculate fresh TSB (1:100, vol/vol). After inoculation, the PAO1
culture was subgrown for 1 h, then aliquoted, and U-50,488 or
dynorphin were added to aliquots to create ﬁnal concentrations of
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rpm, cultures were collected, centrifuged (5,000 rpm, 5 min) to
remove cells, and supernatant was ﬁltered using Millex-CV low
protein binding membrane ﬁlters of 0.22-lm pore size (Millipore).
The ﬁltered supernatant, now termed conditioned media, was stored
on ice before use. L. plantarum and L. rhamnosus GG grown overnight
in MRS broth (Oxoid, http://www.oxoid.com) at 37 8C were used to
inoculate fresh MRS (2:100, vol/vol). Freshly inoculated culture, 100 ll
was put into 96-well plates (Nunc), followed by an addition of 100 ll
of conditioned media from P. aeruginosa. Control samples were
created where 100 ll of TSB; TSBþU-50,488, 200 lM; TSBþdynor-
phin, 100 lM were added to wells. Plates with Lactobacillus spp. were
incubated at 37 8C, unshaken, and growth was monitored dynamically
by measuring OD 600 nm using Plate Reader.
Virulence assay of P. aeruginosa PAO1 using C. elegans. Wild-type
N2 C. elegans were kindly provided by M. Glotzer, University of
Chicago. Culturing, cleaning, egg preparation for synchronization,
and transferring were performed according to ‘‘Maintenance of C.
elegans’’ (http://www.wormbook.org/chapters/www_strainmaintain/
strainmaintain.html). For the experiment, two adult nematodes were
transferred to a lawn of P. aeruginosa on NGM agar prepared by the
following: P. aeruginosa PAO1 and PAO1 derivative DMvfR mutant
were grown for 6 h at 37 8C in TSB (control culture) or TSB
supplemented with U-50,488 (U-50,488 culture), 200 lM, or TSB
supplemented with dynorphin, 100 lM (dynorphin culture). Then, 10
ll of TSB media (control), or TSB supplemented with U-50,488, 1
mM, or dynorphin, 200 lM, was dropped at the center of NGM agar
plate, allowed to dry for 10 min, and then 10 ll of bacterial culture
was dropped on a respective plate (control culture on TSB spot, U-
50,488 culture on U-50,488 spot, and dynorphin culture on
dynorphin spot). The plates were incubated at 37 8C overnight and
allowed to equilibrate to 20 8C for two h before being seeded with
nematodes. The plates with nematodes on P. aeruginosa lawn were
incubated for up to four days at 20 8C, and 4310 ll of TSB, or TSB/
U-50,488, 1 mM, or TSB/dynorphin, 200 lM, were dropped
peripherally at the lawn ring, daily. Total numbers of nematodes
were counted daily.
Data analysis. Statistical analysis of the data was performed using
Student’s t-test. Regression analysis was performed using Sigma plot
software.
Supporting Information
Accession Numbers
The Entrez Protein (http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?db¼Protein) accession numbers for the P. aeruginosa PAO1 gene
products discussed in this paper are citrate synthase (NP_250271),
GacA (NP_251276), LasI (NP_250123), LasR (NP_250121), MvfR
(NP_249694), PA-I galactophilic lectin (NP_251260), RhlI
(NP_252166), and RhlR (NP_252167). The Entrez Nucleotide
(http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db¼Nucleotide) acces-
sion number for the P. aeruginosa PAO1 complete genome is
NC_002516.
Acknowledgments
We thank O. Shevchenko for technical assistance; C. Reimmann for
providing GacA mutant; B. Iglewski for providing LasR, LasI, and RhlI
mutants; P. Greenberg for providing LasI/RhlI mutant; C. Manoil for
providing P. aeruginosa strain MP603; M. Whiteley for providing
plasmid pMW303; H. P. Schweizer for providing pUCP24 plasmid; K.
Winzer for providing PQS; M. Jacobs for providing RhlR and MvfR
mutants; A. Khramtsov and M. Tretiakova for providing histology
staining and examining tissues; H. Auer for assistance in HPLC
puriﬁcation of biotinylated dynorphin; V. Bindokas for assistance
with the preparation of Figure 5 and helpful discussion of electron
and digital microscopy images; and S. Bond for her assistance in the
digital microscopy of intestinal samples.
Author contributions. OZ, TL, MC, AZ, EP, and JCA conceived and
designed the experiments. OZ, FL, GX, VV, YC, TL, MC, AZ, EP, and
JCA performed the experiments. OZ, FL, TL, MC, AZ, EP, JRT, LGR,
and JCA analyzed the data. OZ, FL, GX, YC, EP, LGR, EC, and JCA
contributed reagents/materials/analysis tools. OZ, LGR, EC, and JCA
wrote the paper.
Funding. This work was supported by National Institutes of Health
grants RO1 GM62344–05 (JA) and DK47722 (EC), and Digestive
Disease Research Core Center grant DK42086 (EC).
Competing interests. The authors have declared that no competing
interests exist.
References
1. Dawkins R (2006) The selﬁsh gene. 3rd edition. New York: Oxford
University Press. 384 p.
2. Camilli A, Bassler BL (2006) Bacterial small-molecule signaling pathways.
Science 311: 1113–1116.
3. Wu L, Estrada O, Zaborina O, Bains M, Shen L, et al. (2005) Recognition of
host immune activation by Pseudomonas aeruginosa. Science 309: 774–777.
4. Luo G, Niesel DW, Shaban RA, Grimm EA, Klimpel GR (1993) Tumor
necrosis factor alpha binding to bacteria: Evidence for a high-afﬁnity
receptor and alteration of bacterial virulence properties. Infect Immun 61:
830–835.
5. Porat R, Clark BD, Wolff SM, Dinarello CA (1991) Enhancement of growth
of virulent strains of Escherichia coli by interleukin-1. Science 254: 430–432.
6. Kohler JE, Zaborina O, Wu L, Wang Y, Bethel C, et al. (2005) Components
of intestinal epithelial hypoxia activate the virulence circuitry of
Pseudomonas. Am J Physiol Gastrointest Liver Physiol 288: G1048–G1054.
7. Lacoste A, Jalabert F, Malham SK, Cueff A, Poulet SA (2001) Stress and
stress-induced neuroendocrine changes increase the susceptibility of
juvenile oysters (Crassostrea gigas) to Vibrio splendidus. Appl Environ Micro-
biol 67: 2304–2309.
8. Sperandio V, Torres AG, Jarvis B, Nataro JP, Kaper JB (2003) Bacteria-host
communication: The language of hormones. Proc Natl Acad Sci U S A 100:
8951–8956.
9. Lyte M (2004) Microbial endocrinology and infectious disease in the 21st
century. Trends Microbiol 12: 14–20.
10. Alverdy J, Holbrook C, Rocha F, Seiden L, Wu RL, et al. (2000) Gut-derived
sepsis occurs when the right pathogen with the right virulence genes meets
the right host: Evidence for in vivo virulence expression in Pseudomonas
aeruginosa. Ann Surg 232: 480–489.
11. Bader MW, Sanowar S, Daley ME, Schneider AR, Cho U, et al. (2005)
Recognition of antimicrobial peptides by a bacterial sensor kinase. Cell
122: 461–472.
12. Bishop JL, Finlay BB (2006) Friend or foe? Antimicrobial peptides trigger
pathogen virulence. Trends Mol Med 12: 3–6.
13. Hancock RE, McPhee JB (2005) Salmonella’s sensor for host defense
molecules. Cell 122: 320–322.
14. Sternini C, Patierno S, Selmer IS, Kirchgessner A (2004) The opioid system
in the gastrointestinal tract. Neurogastroenterol Motil 16 (Suppl 2): 3–16.
15. Neudeck BL, Loeb JM (2002) Endomorphin-1 alters interleukin-8 secretion
in Caco-2 cells via a receptor mediated process. Immunol Lett 84: 217–221.
16. Neudeck BL, Loeb J, Buck J (2003) Activation of the kappa-opioid receptor
in Caco-2 cells decreases interleukin-8 secretion. Eur J Pharmacol 467: 81–
84.
17. Vallejo R, de Leon-Casasola O, Benyamin R (2004) Opioid therapy and
immunosuppression: A review. Am J Ther 11: 354–365.
18. Lawrence DM, el-Hamouly W, Archer S, Leary JF, Bidlack JM (1995)
Identiﬁcation of kappa opioid receptors in the immune system by indirect
immunoﬂuorescence. Proc Natl Acad Sci U S A 92: 1062–1066.
19. Karaji AG, Khansari N, Ansary B, Dehpour A (2005) Detection of opioid
receptors on murine lymphocytes by indirect immunoﬂuorescence: Mature
normal and tumor bearing mice lymphocytes. Int Immunopharmacol 5:
1019–1027.
20. Sharp BM, Li MD, Matta SG, McAllen K, Shahabi NA (2000) Expression of
delta opioid receptors and transcripts by splenic T cells. Ann N Y Acad Sci
917: 764–770.
21. Peterson PK, Molitor TW, Chao CC (1998) The opioid-cytokine connection.
J Neuroimmunol 83: 63–69.
22. Wu LR, Zaborina O, Zaborin A, Chang EB, Musch M, et al. (2005) Surgical
injury and metabolic stress enhance the virulence of the human
opportunistic pathogen Pseudomonas aeruginosa. Surg Infect (Larchmt) 6:
185–195.
23. Deziel E, Lepine F, Milot S, He J, Mindrinos MN, et al. (2004) Analysis of
Pseudomonas aeruginosa 4-hydroxy-2-alkylquinolines (HAQs) reveals a role
for 4-hydroxy-2-heptylquinoline in cell-to-cell communication. Proc Natl
Acad Sci U S A 101: 1339–1344.
24. Lau GW, Ran H, Kong F, Hassett DJ, Mavrodi D (2004) Pseudomonas
aeruginosa pyocyanin is critical for lung infection in mice. Infect Immun 72:
4275–4278.
25. Stefano GB, Goumon Y, Casares F, Cadet P, Fricchione GL, et al. (2000)
Endogenous morphine. Trends Neurosci 23: 436–442.
26. Boettcher C, Fellermeier M, Drager B, Zenk MH (2005) How human
neuroblastoma cells make morphine. Proc Natl Acad Sci U S A 102: 8495–
8500.
27. McGrath S, Wade DS, Pesci EC (2004) Dueling quorum sensing systems in
Pseudomonas aeruginosa control the production of the Pseudomonas quinolone
signal (PQS). FEMS Microbiol Lett 230: 27–34.
28. Xiao G, He J, Rahme LG (2006) Mutation analysis of the Pseudomonas
aeruginosa mvfR and pqsABCDE gene promoters demonstrates complex
quorum-sensing circuitry. Microbiology 152: 1679–1686.
29. Deziel E, Gopalan S, Tampakaki AP, Lepine F, Padﬁeld KE, et al. (2005) The
PLoS Pathogens | www.plospathogens.org March 2007 | Volume 3 | Issue 3 | e35 0014
Dynorphin Induces P. aeruginosa Virulencecontribution of MvfR to Pseudomonas aeruginosa pathogenesis and quorum
sensing circuitry regulation: Multiple quorum sensing-regulated genes are
modulated without affecting lasRI, rhlRI or the production of N-acyl- l-
homoserine lactones. Mol Microbiol 55: 998–1014.
30. Diggle SP, Winzer K, Chhabra SR, Worrall KE, Camara M, et al. (2003) The
Pseudomonas aeruginosa quinolone signal molecule overcomes the cell
density-dependency of the quorum sensing hierarchy, regulates rhl-
dependent genes at the onset of stationary phase and can be produced
in the absence of LasR. Mol Microbiol 50: 29–43.
31. Wu L, Zaborina O, Zaborin A, Chang EB, Musch M, et al. (2004) High-
molecular-weight polyethylene glycol prevents lethal sepsis due to
intestinal Pseudomonas aeruginosa. Gastroenterology 126: 488–498.
32. Janecka A, Fichna J, Janecki T (2004) Opioid receptors and their ligands.
Curr Top Med Chem 4: 1–17.
33. Whiteley M, Parsek MR, Greenberg EP (2000) Regulation of quorum sensing
by RpoS in Pseudomonas aeruginosa. J Bacteriol 182: 4356–4360.
34. Gallagher LA, McKnight SL, Kuznetsova MS, Pesci EC, Manoil C (2002)
Functions required for extracellular quinolone signaling by Pseudomonas
aeruginosa. J Bacteriol 184: 6472–6480.
35. Schmidt H, Martindale R (2001) The gastrointestinal tract in critical illness.
Curr Opin Clin Nutr Metab Care 4: 547–551.
36. Marinova Z, Vukojevic V, Surcheva S, Yakovleva T, Cebers G, et al. (2005)
Translocation of dynorphin neuropeptides across the plasma membrane. A
putative mechanism of signal transmission. J Biol Chem 280: 26360–26370.
37. Luyer MD, Buurman WA, Hadfoune M, Speelmans G, Knol J, et al. (2005)
Strain-speciﬁc effects of probiotics on gut barrier integrity following
hemorrhagic shock. Infect Immun 73: 3686–3692.
38. Valdez JC, Peral MC, Rachid M, Santana M, Perdigon G (2005) Interference
of Lactobacillus plantarum with Pseudomonas aeruginosa in vitro and in infected
burns: The potential use of probiotics in wound treatment. Clin Microbiol
Infect 11: 472–479.
39. Mangell P, Nejdfors P, Wang M, Ahrne S, Westrom B, et al. (2002)
Lactobacillus plantarum 299v inhibits Escherichia coli-induced intestinal
permeability. Dig Dis Sci 47: 511–516.
40. Ahrne S, Nobaek S, Jeppsson B, Adlerberth I, Wold AE, et al. (1998) The
normal Lactobacillus ﬂora of healthy human rectal and oral mucosa. J Appl
Microbiol 85: 88–94.
41. Eisenstein LK, MacFarland AS, Peng X, Hilburger ME, Rahim RT, et al.
(2001) Effect of opioids on oral Salmonella infection and immune function.
Adv Exp Med Biol 493: 169–176.
42. Eisenstein TK, Hilburger ME (1998) Opioid modulation of immune
responses: Effects on phagocyte and lymphoid cell populations. J Neuro-
immunol 83: 36–44.
43. Yale CE, Balish E (1972) The importance of six common bacteria in
intestinal strangulation. Arch Surg 104: 438–442.
44. Koury J, Deitch EA, Homma H, Abungu B, Gangurde P, et al. (2004)
Persistent HIF-1alpha activation in gut ischemia/reperfusion injury:
Potential role of bacteria and lipopolysaccharide. Shock 22: 270–277.
45. Stein C, Hassan AH, Przewlocki R, Gramsch C, Peter K, et al. (1990) Opioids
from immunocytes interact with receptors on sensory nerves to inhibit
nociception in inﬂammation. Proc Natl Acad Sci U S A 87: 5935–5939.
46. Cabot PJ, Carter L, Schafer M, Stein C (2001) Methionine-enkephalin-and
Dynorphin A-release from immune cells and control of inﬂammatory pain.
Pain 93: 207–212.
47. McKnight SL, Iglewski BH, Pesci EC (2000) The Pseudomonas quinolone
signal regulates rhl quorum sensing in Pseudomonas aeruginosa. J Bacteriol
182: 2702–2708.
48. Mahajan-Miklos S, Tan MW, Rahme LG, Ausubel FM (1999) Molecular
mechanisms of bacterial virulence elucidated using a Pseudomonas aerugino-
sa-Caenorhabditis elegans pathogenesis model. Cell 96: 47–56.
49. Rahme LG, Tan MW, Le L, Wong SM, Tompkins RG, et al. (1997) Use of
model plant hosts to identify Pseudomonas aeruginosa virulence factors. Proc
Natl Acad Sci U S A 94: 13245–13250.
50. Aliaga L, Mediavilla JD, Cobo F (2002) A clinical index predicting mortality
with Pseudomonas aeruginosa bacteraemia. J Med Microbiol 51: 615–619.
51. Kang CI, Kim SH, Kim HB, Park SW, Choe YJ, et al. (2003) Pseudomonas
aeruginosa bacteremia: Risk factors for mortality and inﬂuence of delayed
receipt of effective antimicrobial therapy on clinical outcome. Clin Infect
Dis 37: 745–751.
52. Marshall JC, Christou NV, Meakins JL (1993) The gastrointestinal tract. The
‘‘undrained abscess’’ of multiple organ failure. Ann Surg 218: 111–119.
53. Marshall JC (1991) The ecology and immunology of the gastrointestinal
tract in health and critical illness. J Hosp Infect 19 (Suppl C): 7–17.
54. Blot S, Vandewoude K, Hoste E, Colardyn F (2003) Reappraisal of
attributable mortality in critically ill patients with nosocomial bacteraemia
involving Pseudomonas aeruginosa. J Hosp Infect 53: 18–24.
55. Baron SS, Rowe JJ (1981) Antibiotic action of pyocyanin. Antimicrob
Agents Chemother 20: 814–820.
56. Wu L, Holbrook C, Zaborina O, Ploplys E, Rocha F, et al. (2003) Pseudomonas
aeruginosa expresses a lethal virulence determinant, the PA-I lectin/adhesin,
in the intestinal tract of a stressed host: The role of epithelia cell contact
and molecules of the Quorum Sensing Signaling System. Ann Surg 238:
754–764.
57. Laughlin RS, Musch MW, Hollbrook CJ, Rocha FM, Chang EB, et al. (2000)
The key role of Pseudomonas aeruginosa PA-I lectin on experimental gut-
derived sepsis. Ann Surg 232: 133–142.
58. Bajolet-Laudinat O, Girod-de Bentzmann S, Tournier JM, Madoulet C,
Plotkowski MC, et al. (1994) Cytotoxicity of Pseudomonas aeruginosa internal
lectin PA-I to respiratory epithelial cells in primary culture. Infect Immun
62: 4481–4487.
59. Jacobs MA, Alwood A, Thaipisuttikul I, Spencer D, Haugen E, et al. (2003)
Comprehensive transposon mutant library of Pseudomonas aeruginosa. Proc
Natl Acad Sci U S A 100: 14339–14344.
60. Essar DW, Eberly L, Hadero A, Crawford IP (1990) Identiﬁcation and
characterization of genes for a second anthranilate synthase in Pseudomonas
aeruginosa: Interchangeability of the two anthranilate synthases and evolu-
tionary implications. J Bacteriol 172: 884–900.
61. Lepine F, Deziel E, Milot S, Rahme LG (2003) A stable isotope dilution assay
for the quantiﬁcation of the Pseudomonas quinolone signal in Pseudomonas
aeruginosa cultures. Biochim Biophys Acta 1622: 36–41.
62. West SE, Schweizer HP, Dall C, Sample AK, Runyen-Janecky LJ (1994)
Construction of improved Escherichia-Pseudomonas shuttle vectors derived
from pUC18/19 and sequence of the region required for their replication
in Pseudomonas aeruginosa. Gene 148: 81–86.
63. Wade DS, Calfee MW, Rocha ER, Ling EA, Engstrom E, et al. (2005)
Regulation of Pseudomonas quinolone signal synthesis in Pseudomonas
aeruginosa. J Bacteriol 187: 4372–4380.
64. Lau GW, Hassett DJ, Ran H, Kong F (2004) The role of pyocyanin in
Pseudomonas aeruginosa infection. Trends Mol Med 10: 599–606.
PLoS Pathogens | www.plospathogens.org March 2007 | Volume 3 | Issue 3 | e35 0015
Dynorphin Induces P. aeruginosa Virulence